GENETIC ANALYSIS |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.64 NOK | -4.48% |
|
+18.52% | -24.71% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Genetic Analysis AS is a Norway-based company active in the field of molecular diagnostics of diseases related to large and small intestine (gut) imbalances. The Company has developed a DNA-based platform technology that allows for simultaneous analysis of a number of similar (but not identical) gene fragments in one reaction. The GA-map platform technology utilizes common and variable DNA sequences within the 16S rRNA gene of the bacteria to characterize and identify the different bacteria. The technology makes it possible to generate profiles of a person's microbiota and correlate that profile to different health conditions.
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -24.71% | 2.44M | |
| -17.89% | 8.25B | |
| +39.20% | 3.57B | |
| -39.11% | 2.46B | |
| -8.06% | 2.46B | |
| -7.35% | 2.38B | |
| -12.61% | 1.81B | |
| -19.01% | 1.55B | |
| -40.66% | 1.21B | |
| +7.56% | 1.11B |
- Stock Market
- Equities
- GEAN Stock
- News Genetic Analysis
- Genetic Analysis Secures Partnership Deal for US Launch of GA-map Microbiome Test
